Hypokalemic Periodic Paralysis

• CLINICAL_TRIALS research · 2026-03-30
  Clinical Trial Update: Effect of Physical Training in Individuals With Hypokalemic and Hyperkalemic Periodic Paralysis [NA]

  This clinical trial update describes a study evaluating the effects of physical training in individuals with hypokalemic and hyperkalemic pe…

• CLINICAL_TRIALS research · 2025-04-08
  Clinical Trial Update: Muscle MRI Outlining of Neuromuscular Diseases Using Artificial Intelligence

  This clinical trial update describes a study using artificial intelligence to outline neuromuscular disease features on MRI. The conditions …

• FDA approval · 2025-01-27
  FDA Approved: ACETAZOLAMIDE — Supplemental Application (Accord Healthcare Inc.)

  FDA approved a supplemental application for Acetazolamide from Accord Healthcare Inc. under an Abbreviated New Drug Application.

• FDA label_change · 2015-08-07
  FDA Approved: KEVEYIS — Supplemental Application (Xeris Pharmaceuticals, Inc.)

  FDA approved a supplemental application for KEVEYIS (dichlorphenamide) from Xeris Pharmaceuticals, updating the product labeling.

• CLINICAL_TRIALS trial_result · 2014-05-30
  Clinical Trial Update: Hyper- and Hypokalemic Periodic Paralysis Study [Phase 3]

  Phase 3 clinical trial evaluating treatment for Hyperkalemic Periodic Paralysis and Hypokalemic Periodic Paralysis has completed, with resul…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.